pipeline problems: exploring the arterial tree
TRANSCRIPT
Clinical Cases
Cardiologists of Tomorrow Track
Pipeline problems: exploring the arterial tree
Acute cor pulmonale: don’t forget the pulmonary tumor thrombotic microangiopathy
Anna Patrignani, Francesca Calcagnoli, Nino Ciampani
Cardiology Department, – Area Vasta n°2 – Senigallia Hospital - Italy
A 56-year-old man came to our attention because of a
two-day history of progressive dyspnoea
Medical history: arterial hypertension, dyslipidemia and
persistent atrial fibrillation
He was in therapy with warfarin, amiodarone, zofenopril
and atorvastatin
Before the present medical contact he showed normal
electrocardiographic and echocardiographic parameters
Physical examination: tachycardia, tachypnoea, few
basilar inspiratory crackles, swelling of multiple lymph
nodes in left sovraclavicular region
Blood pressure: 120/70 mmHg
Arterial gas analysis
Laboratory tests
Mild anaemia: Haemoglobin 12.7 g/dL
Myocardial injury: Troponin I 0.10 ng/mL (nv 0.00-0.06)
Cardiac dysfunction: BNP 591 pg/mL (nv 0-100)
INR in the therapeutic range (2.0)
Elevated plasma D-Dimer 5758 ng/mL (nv 0-300) ”ELISA assay”
The chest radiography showed no evidence of
parenchymal, interstitial or pleural disease
ECG Sinus tachycardia, QT interval prolongation and T wave
inversion in inferior leads and in V1-V5 precordial leads
TAPSE 11 mm PASP 65 mmHg
Right ventricle inflow tract 49 mm
First diagnostic hyphotesis Acute cor pulmonale due to
pulmonary thromboembolism
INR in the therapeutic range
Lower extremity Doppler ultrasound negative for
deep venous thrombosis
?
Computed tomography pulmonary angiogram negative for thromboembolism
It confirmed the absence of alveolar, interstitial or pleural disease
Multiple lymphadenopathy
A lymph node biopsy and a ventilation-perfusion
scintigraphy were planned
Recent onset of dyspnoea
Hypoxaemia / D-Dimer elevated
Acute cor pulmonale with pulmonary hypertension
Clear lung fields on chest radiography
CT scan negative for thromboembolism with
multiple lymphadenopathy
Microscopic
pulmonary
tumor
embolism ??
Patient’s condition progressively worsened, despite fluid,
oxygen and inotropic therapy
He presented a cardiac arrest due to ventricular asystole
and died three days after admission
A post-mortem examination was required
Macroscopic findings
absence of intraparenchimal lung lesions or visible
thrombo-emboli in the major branches of pulmonary vessels
swelling of abdominal and thoracic lymph nodes
enlargement of left adrenal gland
no macroscopic lesions in the remaining abdominal organs
Most of the small pulmonary arteries and arterioles were stenotic or occluded
by fibrocellular intimal proliferation or thrombo-emboli
Microscopic findings of the lung
No tumor cells invaded the vascular wall or the perivascular areas
Primary tumor site could not be confirmed due to the limitation on autopsy
Morfology of the neoplastic cells: poorly differentiated and some signet ring cells
Neoplastic cells were found in left adrenal gland and
in multiple lymph nodes
Surrenal cortex
Residual lymph node
Final diagnosis:
Acute cor pulmonale due to Pulmonary Tumor
Thrombotic Microangiopathy associated with
cancer of unknown origin
It should be distinguished from microscopic tumor embolism
Tumor cells might not only occlude the small arteries and arterioles,
but also activate the coagulation system and release inflammatory
mediators and growth factors resulting in thrombosis, fibrocellular
intimal proliferation and smooth muscle colonization
Pulmonary Tumor Thrombotic Microangiopathy (PTTM)
The reported incidence in patients with solid tumors varies from
0.9-3.3% in autopsy series
Very few cases have been diagnosed antemortem
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
CT pulmonary angiogram
Negative for Thromboembolism
Echocardiogram: first evidence or new onset of pulmonary hypertension ± right ventricular dilatation/dysfunction
Diagnostic hypothesis: Pulmonary Thromboembolism
Hypoxaemia Normal Chest Radiography Laboratory tests
Pulmonary Thromboembolism
Right heart catheterization and blood aspiration
from the catheter in his wedged position
Lung biopsy: CT-guided, transbrochial, open lung
PTTM MPTE
Lung scintigraphy: normal ventilation and non
diagnostic, but atypical, perfusion pattern
Tumor Markers
Breathless differential diagnosis Gavin et al (53)
MPTE (microscopic pulmonary tumor embolism) – PTTM
At the present time, treatment targeting the primary
tumor remains the only therapeutic option
Unfortunately, the poor performance status of most patients at the
time of presentation usually precludes this treatment
Should be considered in the differential diagnosis of
acute/subacute cor pulmonale and pulmonary
hypertension in patients with carcinoma as well as in
noncancer patients
Pulmonary Tumor Thrombotic Microangiopathy
CONCLUSIONS
Clinical Cases
Cardiologists of Tomorrow Track
Thank you for your attention
Anna Patrignani, Francesca Calcagnoli, Nino Ciampani
Cardiology Department, – Area Vasta n°2 – Senigallia Hospital - Italy
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
CT pulmonary angiogram
Negative for Thromboembolism
Echocardiogram: first evidence or new onset of pulmonary hypertension ± right ventricular dilatation/dysfunction
Diagnostic hypothesis: Pulmonary Thromboembolism
Pulmonary Thromboembolism
Right heart cahteterization and blood aspiration
from the catheter in his wedged position
Lung biopsy: CT-guided, transbrochial, open lung
PTTM MPTE
Lung scintigraphy: normal ventilation and non
diagnostic, but atypical, perfusion pattern
Tumor Markers
Breathless differential diagnosis Gavin et al (53)
MPTE (microscopic pulmonary tumor embolism) – PTTM
Hypoxaemia Normal Chest Radiography Laboratory tests
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
CT pulmonary angiogram
Negative for Thromboembolism
Echocardiogram: first evidence or new onset of pulmonary hypertension ± right ventricular dilatation/dysfunction
Diagnostic hypothesis: Pulmonary Thromboembolism
Pulmonary Thromboembolism
Breathless differential diagnosis Gavin et al (53)
Hypoxaemia Normal Chest Radiography Laboratory tests
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
CT pulmonary angiogram
Negative for Thromboembolism
Echocardiogram: first evidence or new onset of pulmonary hypertension ± right ventricular dilatation/dysfunction
Diagnostic hypothesis: Pulmonary Thromboembolism
Right heart cahteterization and blood aspiration
from the catheter in his wedged position
Lung scintigraphy: normal ventilation and non
diagnostic, but atypical, perfusion pattern
MPTE (microscopic pulmonary tumor embolism) – PTTM
(history of carcinoma / lymphadenopathy / laboratory tests, tumor markers…)
Hypoxaemia Normal Chest Radiography Laboratory tests
Algorithm to improve PTTM antemortem diagnosis
MPTE – PTTM
Lung scintigraphy: normal
ventilation and non diagnostic, but
atypical, perfusion pattern
It’s potentially dangerous in patients
with compromised capillary beds and
its sensitivity is unknown
Right heart catheterization and
blood aspiration from the catheter in
his wedged position
Distinguishing tumor cells from
pulmonary megakaryocytes and
endothelial cells is technically
challenging and the sensitivity and
specificity of such testing are
unknown
Algorithm to improve PTTM antemortem diagnosis
Acute/Subacute “Breathless”
CT pulmonary angiogram
Negative for Thromboembolism
Echocardiogram: first evidence or new onset of pulmonary hypertension ± right ventricular dilatation/dysfunction
Diagnostic hypothesis: Pulmonary Thromboembolism
MPTE – PTTM
Lung biopsy: CT-guided, transbrochial, open lung
PTTM MPTE
Lung biopsy remains the diagnostic
gold standard, but there is little
information on the safety of these
procedures in acutely ill patients
with pulmonary hypertension
Hypoxaemia Normal Chest Radiography Laboratory tests
The vascular occlusive lesions seem to develop exclusively in the lung
The onset of symptoms and acute cor pulmonale can be very rapid
whereas the histological features of fibrocellular and fibromuscolar
proliferation take a relatively longtime to develop
Interesting points
Pathogenesis
Possible pathogenetic role of VEGF and TF (transmembrane
glycoprotein that is a major physiologic initiator of blood coagulation),
2A serotonin receptor, osteopontin, PDGF and many vasoactive
molecules.
Expression of TF and VEGF on tumor cells causes increased
coagulation as well as endothelial damage, after which impaired
endothelia produce various growth factors to induce intimal
proliferation